Details for New Drug Application (NDA): 212595
✉ Email this page to a colleague
The generic ingredient in RIOMET ER is metformin hydrochloride. There are forty-nine drug master file entries for this compound. Eighty-nine suppliers are listed for this compound. Additional details are available on the metformin hydrochloride profile page.
Summary for 212595
Tradename: | RIOMET ER |
Applicant: | Sun Pharm |
Ingredient: | metformin hydrochloride |
Patents: | 1 |
Medical Subject Heading (MeSH) Categories for 212595
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | FOR SUSPENSION, EXTENDED RELEASE;ORAL | Strength | 500MG/5ML | ||||
Approval Date: | Aug 29, 2019 | TE: | RLD: | Yes | |||||
Patent: | ⤷ Sign Up | Patent Expiration: | May 1, 2035 | Product Flag? | Y | Substance Flag? | Delist Request? |
Complete Access Available with Subscription